Malouh Marwa A, Cichero Julie A Y, Sun Yu, Lau Esther T L, Nissen Lisa M, Steadman Kathryn J
School of Pharmacy, The University of Queensland, Brisbane, QLD 4072, Australia.
Centre for Business and Economics of Health, The University of Queensland, Brisbane, QLD 4072, Australia.
Pharmaceutics. 2024 Mar 18;16(3):417. doi: 10.3390/pharmaceutics16030417.
Swallowing oral solid dosage forms is challenging for those who have medication swallowing difficulties, including patients with dysphagia. One option is to mix the drug (whole or crushed) with a thick vehicle (medication lubricant). Previous in vitro studies consistently suggest that thick vehicles could impact the dissolution of solid dosage forms, potentially influencing their therapeutic effectiveness, but do not account for changes that happen during oral processing and swallowing. This study aims to investigate the potential impact of medication lubricants on drug release and examine the effect of oral processing. In vitro dissolution of whole and crushed paracetamol tablets mixed with five commercially available medication lubricants (two IDDSI level 2, two IDDSI level 3, and one IDDSI level 4) were tested with and without oral processing; a medication lubricant with/without paracetamol was placed in the mouth (five healthy volunteers), prepared for swallowing, but then expectorated and assessed for physical characteristics and drug release. Medication lubricants, both alone and mixed with crushed paracetamol tablets, showed a significant decrease in viscosity after oral processing. Without oral processing, IDDSI level 3 and 4 lubricants significantly delayed the dissolution of paracetamol tablets. After oral processing, particularly with crushed tablets, there was a substantial increase in the dissolution rate. These findings suggest that dissolution testing overestimates the impact of medication lubricants on drug dissolution. Therefore, using in vitro dissolution tests to predict the dissolution rate of medications mixed with thick vehicles is discouraged. It is essential to consider ways to incorporate the effects of the oral environment and oral processing on thick vehicles used for oral medication administration.
对于那些有药物吞咽困难的人,包括吞咽困难的患者来说,吞咽口服固体剂型具有挑战性。一种选择是将药物(完整或碾碎)与浓稠载体(药物润滑剂)混合。先前的体外研究一致表明,浓稠载体可能会影响固体剂型的溶解,从而可能影响其治疗效果,但并未考虑口腔处理和吞咽过程中发生的变化。本研究旨在调查药物润滑剂对药物释放的潜在影响,并研究口腔处理的作用。测试了完整和碾碎的扑热息痛片与五种市售药物润滑剂(两种国际吞咽障碍饮食标准化倡议组织(IDDSI)2级、两种IDDSI 3级和一种IDDSI 4级)混合后的体外溶解情况,有或没有口腔处理;将含或不含扑热息痛的药物润滑剂置于口腔中(五名健康志愿者),准备吞咽,但随后咳出并评估其物理特性和药物释放情况。药物润滑剂单独使用以及与碾碎的扑热息痛片混合使用时,口腔处理后粘度均显著降低。在没有口腔处理的情况下,IDDSI 3级和4级润滑剂显著延迟了扑热息痛片的溶解。口腔处理后,尤其是碾碎的片剂,溶解速率大幅提高。这些发现表明,溶出度测试高估了药物润滑剂对药物溶解的影响。因此,不建议使用体外溶出度测试来预测与浓稠载体混合的药物的溶解速率。必须考虑如何纳入口腔环境和口腔处理对用于口服给药的浓稠载体的影响。